Baran, B. Et Al. 2013. Tenofovir disoproxil fumarate has a substantial efficacy against adefovir and multi-drug resistant strains of hepatitis B virus. 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases , (Washington, Kiribati).

Baran, B., Soyer, O. M., Ormeci, A., Gokturk, S., Evirgen, S., Akyuz, F., ... Karaca, C.(2013). Tenofovir disoproxil fumarate has a substantial efficacy against adefovir and multi-drug resistant strains of hepatitis B virus . 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati

Baran, Bülent Et Al. "Tenofovir disoproxil fumarate has a substantial efficacy against adefovir and multi-drug resistant strains of hepatitis B virus," 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 2013

Baran, Bülent Et Al. "Tenofovir disoproxil fumarate has a substantial efficacy against adefovir and multi-drug resistant strains of hepatitis B virus." 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases , Washington, Kiribati, 2013

Baran, B. Et Al. (2013) . "Tenofovir disoproxil fumarate has a substantial efficacy against adefovir and multi-drug resistant strains of hepatitis B virus." 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases , Washington, Kiribati.

@conferencepaper{conferencepaper, author={Bülent BARAN Et Al. }, title={Tenofovir disoproxil fumarate has a substantial efficacy against adefovir and multi-drug resistant strains of hepatitis B virus}, congress name={64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases}, city={Washington}, country={Kiribati}, year={2013}}